Lorenzo Piergallini

Lorenzo Piergallini

Auto-generated profile, based on publicly available information

Lorenzo Piergallini

Department of Neuroscience (L.P., S.D., G.C., P.R., C.F., S.B.), Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
LPLorenzo Piergallini
Lorenzo Piergallini
FCFederico Cagnazzo
Federico Cagnazzo
GCGiorgio Conte
Giorgio Conte
CDCyril Dargazanli
Cyril Dargazanli
IDImad Derraz
Imad Derraz
VCVincent Costalat
Vincent Costalat
Introduction During flow diversion, the choice of the length, diameter, and location of the deployed stent are critical for the success of the procedure. Sim&Size software, based on the three-dimensional rotational angiography (3D-RA) acquisition, simulates the release of the stent, suggesting optimal sizing, and displaying the degree of the wall apposition. Objective To demonstrate technical and clinical impacts of the Sim&Size simulation during treatment with the Pipeline Flex Embolization Device. Methods Consecutive patients who underwent aneurysm embolization with Pipeline at our department were retrospectively enrolled (January 2015–December 2017) and divided into two groups: treated with and without simulation. Through univariate and multivariate models, we evaluated: (1) rate of corrective intervention for non-optimal stent placement, (2) duration of intervention, (3) radiation dose, and (4) stent length. Results 189 patients, 95 (50.2%) without and 94 (49.7%) with software assistance were analyzed. Age, sex, comorbidities, aneurysm characteristics, and operator’s experience were comparable among the two groups. Procedures performed with the software had a lower rate of corrective intervention (9% vs 20%, p=0.036), a shorter intervention duration (46 min vs 52 min, p=0.002), a lower median radiation dose (1150 mGy vs 1558 mGy, p<0.001), and a shorter stent length (14 mm vs 16 mm, p<0.001). Conclusions In our experience, the use of the virtual simulation during Pipeline treatment significantly reduced the need for corrective intervention, the procedural time, the radiation dose, and the length of the stent.

7 February 2019 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JOJ.M. Ospel
J.M. Ospel
GGG. Gascou
G. Gascou
VCV. Costalat
V. Costalat
LPL. Piergallini
L. Piergallini
KBK.A. Blackham
K.A. Blackham
DZD.W. Zumofen
D.W. Zumofen
BACKGROUND AND PURPOSE: The Sim&Size software simulates case-specific intraluminal Pipeline Embolization Device behavior, wall apposition, and device length in real-time on the basis of rotational angiography DICOM data. The purpose of this multicenter study was to evaluate whether preimplantation device simulation with the Sim&Size software results in selection of different device dimensions than manual sizing. MATERIALS AND METHODS: In a multicenter cohort of 74 patients undergoing aneurysm treatment with the Pipeline Embolization Device, we compared apparent optimal device dimensions determined by neurointerventionalists with considerable Pipeline Embolization Device experience based on manual 2D measurements taken from rotational angiography with computed optimal dimensions determined by Sim&Size experts blinded to the neurointerventionalists9 decision. Agreement between manually determined and computed optimal dimensions was evaluated with the Cohen κ. The significance of the difference was analyzed with the Wilcoxon signed rank test. RESULTS: The agreement index between manual selection and computed optimal dimensions was low (κ for diameter = 0.219; κ for length = 0.149, P < .01). Computed optimal device lengths were significantly shorter (median, 14 versus 16 mm, T = 402, r = −0.28, P < .01). No significant difference was observed for device diameters. CONCLUSIONS: Low agreement between manually determined and computed optimal device dimensions is not proof, per se, that virtual simulation performs better than manual selection. Nevertheless, it ultimately reflects the potential for optimization of the device-sizing process, and use of the Sim&Size software reduces, in particular, device length. Nevertheless, further evaluation is required to clarify the impact of device-dimension modifications on outcome.

1 August 2019 in World Neurosurgery
Verified
Journal Article
Closed access
LPLorenzo Piergallini
Lorenzo Piergallini
CDCyril Dargazanli
Cyril Dargazanli
IDImad Derraz
Imad Derraz
VCVincent Costalat
Vincent Costalat

31 July 2024 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
PCPaola Maria Francesca Cristaldi
Paola Maria Francesca Cristaldi
CRChiara Benedetta Rui
Chiara Benedetta Rui
LPLorenzo Piergallini
Lorenzo Piergallini
ACAndrea Di Cristofori
Andrea Di Cristofori
MPMirko Patassini
Mirko Patassini
GCGiorgio Giovanni Carrabba
Giorgio Giovanni Carrabba

1 May 2020 in World Neurosurgery
Verified
Journal Article
Closed access
LPLorenzo Piergallini
Lorenzo Piergallini
ACAmedeo Cervo
Amedeo Cervo
AMAntonio Macera
Antonio Macera
MPMariangela Piano
Mariangela Piano
GPGuglielmo Pero
Guglielmo Pero

1 March 2026 in Stroke: Vascular and Interventional Neurology
Verified
Journal Article
Open access
FPFrancesco Andrea Pedrazzini
Francesco Andrea Pedrazzini
LPLorenzo Piergallini
Lorenzo Piergallini
SDSusanna Diamanti
Susanna Diamanti
EFEnrico Fainardi
Enrico Fainardi
SVSergio Lucio Vinci
Sergio Lucio Vinci
SBSimone Beretta
Simone Beretta
BACKGROUND: Collateral blood flow is a critical determinant of successful recanalization in acute ischemic stroke caused by large vessel occlusion. Head down tilt −15° (HDT15), similar to Trendelenburg positioning, is a simple, low-cost positional therapy that may augment cerebral collateral blood flow and penumbral survival. The aim of the study is to assess the safety, feasibility, and efficacy of HDT15 in improving cerebral collateral circulation and clinical outcomes in patients with large vessel occlusion–acute ischemic stroke treated with mechanical thrombectomy (MT). METHODS: The DOWN-SUITE trial (Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke) is a multicenter, randomized, open-label, phase 2a/b clinical trial with blinded outcome assessment, conducted across 7 Italian stroke centers. A total of 118 patients with acute ischemic stroke due to M1 segment middle cerebral artery occlusion will be randomized 1:1 in the emergency department to receive HDT15 or standard positioning (head-of-bed 0° to +30°) before and during MT. RESULTS: The primary end point is good collateral status (American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology grade 3–4), assessed on the first angiographic sequence during MT by a blinded imaging core laboratory. Secondary end points include feasibility (proportion maintaining HDT15, admission-to-MT time), safety (symptomatic intracranial hemorrhage, pneumonia, vomiting, neurological deterioration, vital signs), and efficacy (neurological improvement before MT, at 24 hours, and at 7 days or discharge, modified Rankin Scale score at 90 days). CONCLUSIONS: The DOWN-SUITE trial will provide evidence on the acute cerebrovascular effect of HDT15 in large vessel occlusion–acute ischemic stroke, potentially establishing a cost-effective, practice-changing intervention to improve collaterals for global stroke care. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06297863.